NCT06432192View on ClinicalTrials.gov

A Prospective, Monocentric Clinical Study for the Validation of in Vitro Diagnostic Tests Developed by Firalis

CompletedOBSERVATIONAL
Enrollment

1,474

Participants

Timeline

Start Date

January 2, 2024

Primary Completion Date

March 25, 2025

Study Completion Date

March 25, 2025

Conditions
Genetic Health Risks
Interventions
DIAGNOSTIC_TEST

APO-Easy

Testing for the APOE genotype using the APO-Easy Genotyping test

Trial Locations (2)

54100

EFS GEST, Nancy

67000

EFS GEST, Strasbourg

Sponsors

Lead Sponsor

Firalis SA
All Listed Sponsors
lead

Firalis SA

INDUSTRY

NCT06432192 - A Prospective, Monocentric Clinical Study for the Validation of in Vitro Diagnostic Tests Developed by Firalis | Biotech Hunter | Biotech Hunter